Suppr超能文献

比较 CSF 神经丝轻链、神经颗粒素和 tau 与 MRI 标志物。

Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.

机构信息

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Alzheimers Dement. 2021 May;17(5):801-812. doi: 10.1002/alz.12239. Epub 2021 Mar 4.

Abstract

INTRODUCTION

We determined whether cerebrospinal fluid (CSF) neurofilament light (NfL), neurogranin (Ng), and total-tau (t-tau) differentially mapped to magnetic resonance imaging (MRI) measures of cortical thickness, microstructural integrity (corpus callosum and cingulum fractional anisotropy [FA]), and white matter hyperintensities (WMH).

METHODS

Analyses included 536 non-demented Mayo Clinic Study of Aging participants with CSF NfL, Ng, t-tau, amyloid beta (Aβ)42 and longitudinal MRI scans. Linear mixed models assessed longitudinal associations between CSF markers and MRI changes.

RESULTS

Higher CSF NfL was associated with decreasing microstructural integrity and WMH. Higher t-tau was associated with decreasing temporal lobe and Alzheimer's disease (AD) meta region of interest (ROI) cortical thickness. There was no association between Ng and any MRI measure. CSF Aβ42 interacted with Ng for declines in temporal lobe and AD meta ROI cortical thickness and cingulum FA.

DISCUSSION

CSF NfL predicts changes in white matter integrity, t-tau reflects non-specific changes in cortical thickness, and Ng reflects AD-specific synaptic and neuronal degeneration.

摘要

简介

我们确定了脑脊液(CSF)神经丝轻链(NfL)、神经颗粒素(Ng)和总 tau(t-tau)是否与磁共振成像(MRI)测量的皮质厚度、微观结构完整性(胼胝体和扣带回分数各向异性 [FA])和脑白质高信号(WMH)有差异。

方法

分析包括 536 名无痴呆的梅奥诊所老龄化研究参与者的 CSF NfL、Ng、t-tau、淀粉样蛋白β(Aβ)42 和纵向 MRI 扫描。线性混合模型评估了 CSF 标志物与 MRI 变化之间的纵向关联。

结果

较高的 CSF NfL 与微观结构完整性和 WMH 的减少有关。较高的 t-tau 与颞叶和阿尔茨海默病(AD)的 ROI 皮质厚度减少有关。Ng 与任何 MRI 测量都没有关联。CSF Aβ42 与 Ng 相互作用,导致颞叶和 AD 元 ROI 皮质厚度以及扣带回 FA 的下降。

讨论

CSF NfL 预测白质完整性的变化,t-tau 反映皮质厚度的非特异性变化,而 Ng 反映 AD 特异性的突触和神经元退化。

相似文献

1
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.
Alzheimers Dement. 2021 May;17(5):801-812. doi: 10.1002/alz.12239. Epub 2021 Mar 4.
2
Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures.
Hum Brain Mapp. 2020 Jun 1;41(8):2004-2013. doi: 10.1002/hbm.24925. Epub 2020 Jan 16.
3
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease.
Neurobiol Aging. 2017 Oct;58:14-29. doi: 10.1016/j.neurobiolaging.2017.06.002. Epub 2017 Jun 17.
7
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.
Alzheimers Dement. 2019 Nov;15(11):1437-1447. doi: 10.1016/j.jalz.2019.07.009. Epub 2019 Oct 23.
10
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.
EMBO Mol Med. 2016 Oct 4;8(10):1184-1196. doi: 10.15252/emmm.201606540. Print 2016 Oct.

引用本文的文献

1
CSF total tau as a proxy of synaptic degeneration.
Nat Commun. 2025 Aug 29;16(1):8076. doi: 10.1038/s41467-025-63545-5.
3
Roles of neuroimaging markers and biomarkers in cerebral small vessel disease and their associations with cognitive function.
Front Neurol. 2025 May 1;16:1483842. doi: 10.3389/fneur.2025.1483842. eCollection 2025.
4
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial.
Nat Med. 2024 Jun;30(6):1761-1770. doi: 10.1038/s41591-024-02977-w. Epub 2024 May 17.
5
Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations.
Alzheimers Dement (N Y). 2023 Nov 17;9(4):e12434. doi: 10.1002/trc2.12434. eCollection 2023 Oct-Dec.
7
Sex-specific effects of SNAP-25 genotype on verbal memory and Alzheimer's disease biomarkers in clinically normal older adults.
Alzheimers Dement. 2023 Aug;19(8):3448-3457. doi: 10.1002/alz.12989. Epub 2023 Feb 18.
9
Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design.
Alzheimers Dement. 2023 Jan;19(1):318-332. doi: 10.1002/alz.12814. Epub 2022 Oct 14.
10
Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity.
Front Aging Neurosci. 2022 Jul 11;14:930315. doi: 10.3389/fnagi.2022.930315. eCollection 2022.

本文引用的文献

1
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
Alzheimers Dement. 2020 Oct;16(10):1358-1371. doi: 10.1002/alz.12131. Epub 2020 Jun 23.
2
Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions.
Mayo Clin Proc. 2020 Jun;95(6):1195-1205. doi: 10.1016/j.mayocp.2020.01.028.
3
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
EMBO Mol Med. 2019 Dec;11(12):e11170. doi: 10.15252/emmm.201911170. Epub 2019 Nov 11.
4
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.
Alzheimers Dement. 2019 Nov;15(11):1437-1447. doi: 10.1016/j.jalz.2019.07.009. Epub 2019 Oct 23.
6
White matter hyperintensities: relationship to amyloid and tau burden.
Brain. 2019 Aug 1;142(8):2483-2491. doi: 10.1093/brain/awz162.
7
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline.
Alzheimers Dement (N Y). 2019 Apr 12;5:129-138. doi: 10.1016/j.trci.2019.02.004. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验